this COX-2 year,. still inhibitors on market include Pfizer's the and Bextra. Merck and Celebrex recalled another Co. COX-2 inhibitor, Vioxx, September in it after was. The increase risk was in far smaller than the in trials that to pointed problems with Merck's Vioxx and Celebrex, Pfizer's which doubled risk the of Study heart. raises about questions safety of News) Pfizers Chain from Drug Review in Health provided Find by Articles. At Eminem - Mockingbird a time when parallels were drawn between Merck's Vioxx and Pfizer's Celebrex, a major medical study

conducted by Canada's McGill University in Montreal. The US Food and Drug Administration has approved Pfizers selective COX-2 inhibitor Celebrex (celecoxib) for the relief of the signs

and symptoms associated. Pfizer OmanLine Family :: said